Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
![](../../images/overlap_matrix_icon.png)
14
Number of overlapping holdings
53.8%
% of BBH's 28 holdings also in BBP
23.0%
% of BBP's 65 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BBH |
Weight in BBP |
Overlap | |
---|---|---|---|---|
ALNYLAM PHARMACEUTICALS INC | 3.4% | 2.1% | 2.1% | |
GILEAD SCIENCES INC | 7.8% | 1.8% | 1.8% | |
SAREPTA THERAPEUTICS INC | 2.4% | 1.7% | 1.7% | |
AMGEN INC | 15.4% | 1.6% | 1.6% | |
NEUROCRINE BIOSCIENCES INC | 2.5% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to BBP
AMGEN INC | 13.8% | |
VERTEX PHARMACEUTICALS INC | 8.3% | |
REGENERON PHARMACEUTICALS | 7.2% | |
GILEAD SCIENCES INC | 6.0% | |
ARGENX SE ADR | 5.7% | |
IQVIA HOLDINGS INC | 5.4% | |
ILLUMINA INC | 4.2% | |
ICON PLC | 4.2% | |
NATERA INC | 2.7% | |
BEIGENE LTD. SPONSORED ADR | 2.5% |
BBH Underweight Relative to BBP
MIRUM PHARMACEUTICALS, INC. | -2.4% | |
TRAVERE THERAPEUTICS, INC. | -2.0% | |
LIGAND PHARMACEUTICALS-CL B | -1.9% | |
LEXICON PHARMACEUTICALS, INC. | -1.9% | |
LEGEND BIOTECH CORPORATION SPONSORED | -1.9% | |
ACADIA PHARMACEUTICALS INC | -1.9% | |
BIOCRYST PHARMACEUTICALS INC | -1.8% | |
IONIS PHARMACEUTICALS, INC. | -1.8% | |
DAY ONE BIOPHARMACEUTICALS, INC. | -1.8% | |
TG THERAPEUTICS INC | -1.8% |